Quest Diagnostics
DGX • NYSE
Quest Diagnostics is a medical - diagnostics & research company in the healthcare sector trading on NYSE, led by CEO James E. Davis, with a market cap of $21.5B.
CEOJames E. Davis
Next Earnings
Upcoming earnings announcement for Quest Diagnostics
Date
Tuesday, April 21, 2026 (in 3 weeks)
Timing
Before Market Open (6:45 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$2.36
Revenue Estimate
$2.8B
Earnings History
Past 12 earnings reports for Quest Diagnostics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q4 2025 | $2.42Est: $2.35 | +3.0% | $2.8BEst: $2.8B | +1.8% |  10-K |
| Oct 21, 2025 | Q3 2025 | $2.60Est: $2.51 | +3.6% | $2.8BEst: $2.7B | +3.2% | 10-Q |
| Jul 22, 2025 | Q2 2025 | $2.62Est: $2.57 | +1.9% | $2.8BEst: $2.7B | +1.4% | 10-Q |
| Apr 22, 2025 | Q1 2025 | $2.21Est: $2.15 | +2.8% | $2.7BEst: $2.6B | +0.8% | 10-Q |
| Jan 30, 2025 | Q4 2024 | $2.23Est: $2.18 | +2.3% | $2.6BEst: $2.6B | +1.6% | 10-K |
| Oct 22, 2024 | Q3 2024 | $2.30Est: $2.26 | +1.8% | $2.5BEst: $2.4B | +2.8% | 10-Q |
| Jul 23, 2024 | Q2 2024 | $2.35Est: $2.34 | +0.4% | $2.4BEst: $2.4B | +0.3% | 10-Q |
| Apr 23, 2024 | Q1 2024 | $2.04Est: $1.85 | +10.3% | $2.4BEst: $2.3B | +3.3% | 10-Q |
| Feb 1, 2024 | Q4 2023 | $2.15Est: $2.11 | +1.9% | $2.3BEst: $2.3B | +1.7% | 10-K |
| Oct 24, 2023 | Q3 2023 | $2.22Est: $2.19 | +1.4% | $2.3BEst: $2.3B | +1.1% | 10-Q |
| Jul 26, 2023 | Q2 2023 | $2.30Est: $2.27 | +1.3% | $2.3BEst: $2.3B | +3.9% | — |
| Apr 27, 2023 | Q1 2023 | $2.04Est: $1.97 | +3.6% | $2.3BEst: $2.2B | +6.0% | — |